Jian, W., Feng-zhen, Y., Min, Z. et al. Randomized double-blinded and controlled clinical trial on treatment of HIV/AIDS by Zhongyan-4., Chin. J. Integr. Med. 12, 6–11 (2006). https://doi.org/10.1007/BF02857422
Wang Jian, Yang Feng-zhen, Zhao Min, et al. Randomized double-blinded and controlled clinical trial on treatment of HIV/AIDS by Zhongyan-4[J]. Chinese Journal of Integrative Medicine, 2006,12(1):6-11.
Jian, W., Feng-zhen, Y., Min, Z. et al. Randomized double-blinded and controlled clinical trial on treatment of HIV/AIDS by Zhongyan-4., Chin. J. Integr. Med. 12, 6–11 (2006). https://doi.org/10.1007/BF02857422DOI:
Wang Jian, Yang Feng-zhen, Zhao Min, et al. Randomized double-blinded and controlled clinical trial on treatment of HIV/AIDS by Zhongyan-4[J]. Chinese Journal of Integrative Medicine, 2006,12(1):6-11. DOI: 10.1007/BF02857422.
Randomized double-blinded and controlled clinical trial on treatment of HIV/AIDS by Zhongyan-4
摘要
Objective: To assess the efficacy and safety of Zhongyan-4 (ZY-4
a Chinese herbal preparation worked out according to the therapeutic principle of supplementing qi
nourishing Yin
clearing heat and detoxication) in treating HIV/AIDS patients in the early or middle stage.Methods: Adopted was randomized double-blinded and placebo-parallel-controlled method
with 72 HIV/AIDS patients randomly divided into the ZY-4 group (36 patients) treated with ZY-4 and the control group (36 patients) treated with placebo. The treatment course was six months. The index of CD 4 +
CD 8 + counts
body weight
clinical symptom scoring were estimated at 4 time points (0
1
3 and 6 month in the course)
and also the viral load before and after treatment. The whole course of observation was completed in 63 patients
30 in the ZY-4 group and 33 in the control group.Results: CD 4 + count in the ZY-4 group got elevated by 7.70 ± 150.96/mm3 on average
while that in the control group lowered by 27.33 ± 85.28 /mm3. Fifteen out of the 30 patients in the ZY-4 group had their CD 4 + count increased
which was evidently much higher than that in the control group (8/33
P<0.05)
suggesting that the efficacy of ZY-4 is superior to that of placebo in elevating CD 4 + count. Moreover
ZY-4 showed actions in elevating CD45RA+ and CD 8 + count
reducing HIV virus load
improving clinical symptom/sign and increasing body weight of patients. No obvious adverse reaction was found in the clinical trial.Conclusion: ZY-4 has an immunity-protective and/or rebuilding function in HIV/AIDS patients in the early and middle stage
and also shows effects in lowering viral load
increasing body weight and improving symptoms and signs to a certain degree.
Abstract
Objective: To assess the efficacy and safety of Zhongyan-4 (ZY-4
a Chinese herbal preparation worked out according to the therapeutic principle of supplementing qi
nourishing Yin
clearing heat and detoxication) in treating HIV/AIDS patients in the early or middle stage.Methods: Adopted was randomized double-blinded and placebo-parallel-controlled method
with 72 HIV/AIDS patients randomly divided into the ZY-4 group (36 patients) treated with ZY-4 and the control group (36 patients) treated with placebo. The treatment course was six months. The index of CD 4 +
CD 8 + counts
body weight
clinical symptom scoring were estimated at 4 time points (0
1
3 and 6 month in the course)
and also the viral load before and after treatment. The whole course of observation was completed in 63 patients
30 in the ZY-4 group and 33 in the control group.Results: CD 4 + count in the ZY-4 group got elevated by 7.70 ± 150.96/mm3 on average
while that in the control group lowered by 27.33 ± 85.28 /mm3. Fifteen out of the 30 patients in the ZY-4 group had their CD 4 + count increased
which was evidently much higher than that in the control group (8/33
P<0.05)
suggesting that the efficacy of ZY-4 is superior to that of placebo in elevating CD 4 + count. Moreover
ZY-4 showed actions in elevating CD45RA+ and CD 8 + count
reducing HIV virus load
improving clinical symptom/sign and increasing body weight of patients. No obvious adverse reaction was found in the clinical trial.Conclusion: ZY-4 has an immunity-protective and/or rebuilding function in HIV/AIDS patients in the early and middle stage
and also shows effects in lowering viral load
increasing body weight and improving symptoms and signs to a certain degree.
关键词
HIV/AIDSprinciple for supplementing Qinourishing Yinclearing heat and detoxicationZhongyan-4T-Iymphocyte subsetsHIV viral load
Keywords
HIV/AIDSprinciple for supplementing Qinourishing Yinclearing heat and detoxicationZhongyan-4T-Iymphocyte subsetsHIV viral load
references
John G Bartlett, Joel E Callant. Diagnosis and treatment of HIV infection. Beijing: Science Publication Press, 2002: 2.
Su CL. Primary research of clinical treatment of AIDS. J Tradit Chin Med 1990;31(2): 26–29.
Jiang XY. The pathogenesis of AIDS. J Chin Med 2001; 16(6): 41–42.
Huang BS. The treatment of AIDS with TCM. Harbin: Heilongjiang Science and Technology Publishing House, 1990: 25.
Xue BS. The knowledge of HIV/AIDS with TCM theory. J Tradit Chin Med 1991;32(1): 20.
Yang FZ, Yan JH. Exploring Yuan Qi theory in HIV/AIDS. J Basic Theory Tradit Chin Med 2003; 9(8): 4–5.
Yang FZ. Wang J. Developing research of HIV/AIDS in the TCM pathogenesis. J Inform Tradit Chin Med 2004; 11 (4): 365–367.
Lu WB, editor. Preventing and treating HIV/AIDS. Beijing: People’s Medical Publishing Hourse, 1994: 170–181.
Jian TJ, Zhao M.Wang J, et al. Clinical research of liver damage of HIV complicated with HCV infection. J New Chin Materia Med 2004; 3(4): 22–24.
Yang FZ, Wang J, Zhao M, et al. The relativity research of traditional Chinese medicine syndromes and T lymphocyte and virus loading. China J Tradit Chin Med Pharmacy 2004: 19(12): 733–737.
Effect of Chinese herbal medicine for nourishing yin, supplementing qi, and activating blood on the Th1/Th2 immune balance in peripheral blood in patients with primary Sjogren’s syndrome
Effect of Immune No. 2 (免疫2号方) on the immune reconstitution in patients with HIV/AIDS after highly active antiretroviral treatment: A randomized double blind placebo controlled clinical trial
Therapeutic effect of Chinese herbal medicine for strengthening qi, nourishing yin, and removing stasis on serum osteopontin and quality of life of patients with primary Sjogren's syndrome
Effect of Chinese herbal medicines for nourishing yin, supplementing qi, and activating blood on reproductive endocrine activity and immune functions in patients with primary Sjogren’s syndrome
相关作者
暂无数据
相关机构
The First Affiliated Hospital of Medical College of Zhejiang University
Zhejiang University of Chinese Medicine
Guang’anmen Hospital, China Academy of Chinese Medical Sciences
The First Affiliated Hospital of Medical School of Zhejiang University